What is the primary indication for Novolog?

Novolog is primarily indicated for the treatment of insulin-dependent diabetes, which includes both Type 1 and Type 2 diabetes where insulin is required for blood sugar regulation. This rapid-acting insulin allows patients to manage blood glucose levels effectively, particularly during mealtime. It works by mimicking the way the body normally releases insulin in response to food intake, helping to prevent hyperglycemia after meals.

The other options do not pertain to the indications for Novolog. Treatment of anxiety involves medications that are not related to insulin, while management of muscle spasticity typically involves muscle relaxants or other specific therapies. Additionally, treating bacterial infections would require antibiotics, which are also unrelated to the function of insulin. This highlights the specialized role of Novolog in diabetes management.